MedTrace Logo

Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers

NCT01924676 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2015-08-31

No results posted yet for this study

Summary

To estimate the effects of food on oxycodone pharmacokinetics after administration of 40 mg doses of PF-00345439 Formulation K and to estimate its relative bioavailability compared to PF-00345439 Formulation X in the fasted state in healthy volunteers

Conditions

  • Healthy

Interventions

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation X, single dose, under fasting conditions

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation K, single dose, under fasting conditions

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation K, single dose, under fed conditions

Sponsors & Collaborators

  • Pain Therapeutics

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01924676 on ClinicalTrials.gov